Overview
As the universe of artificial intelligence (AI) expands its horizons and technologies continue to evolve, health care and life sciences companies seek EBG Advisors for guidance on applying emerging tools, exploring opportunities, and navigating unprecedented challenges.
Just as AI and machine learning tools do, our clients span industries and include those in human resources, talent acquisition, health care, and life sciences.
Our Services
EBG Advisors is well equipped to assist clients with a wide range of AI-related matters, with a team of data scientists, social scientists, and attorneys experienced in areas including:
- Policy analysis
- Privacy and data protection
- Data analytics
- Performance improvement
- Payment/reimbursement for services and technologies
- Developer and user algorithm bias testing
- Team training on the responsible use of data science and process validation
Enhancing the scope of these services, our team of data scientists, social scientists, and attorneys offers a close analysis of where unintended discrimination and bias might arise, proactively advising clients on potential or existing risks and offering the guidance needed to address these scenarios. Our team is experienced at building models across sectors, assessing for bias, and training on the responsible use of data science and the validation of processes, feature selection and engineering, model selection, and model results in close collaboration with Epstein Becker Green attorneys.
Events
Past Events
- August 25, 2022
- June 14, 2022
- June 9, 2022
- December 9, 2021
- September 30, 2021
Insights
Insights
- AnnouncementsEBG Advisors Selected to Help Launch NIST’s U.S. AI Safety Institute Consortium3 minute read
- PublicationsWhat GCs Need to Know About Algorithmic Bias3 minute read
- BlogsFDA Oversight of AI Software Developed by Health Care Providers23 minute read
- Media CoverageEpstein Becker Green Forms Collaboration with Data, Social Scientists for AI Consulting5 minute read
- AnnouncementsEBG Advisors and Epstein Becker Green Expand AI Advisory Capabilities Backed by Nearly 1,000 Projects Across Hundreds of ...5 minute read
- Media CoverageBradley Merrill Thompson Quoted in “Ready or Not, AI Chatbots Are Coming to Hospitals”3 minute read
- PublicationsWhy a Data Scientist Needs a Lawyer to Correct Algorithmic Discrimination4 minute read
- Media CoverageBradley Merrill Thompson Quoted in “FDA Draft Guidance Allows AI/ML Devices to Evolve Without Requiring New ...5 minute read
- Media CoverageBradley Merrill Thompson Quoted in “FDA Draft Guidance for AI Change Control Shifts Workload to Initial Premarket ...1 minute read
- Media CoverageBradley Merrill Thompson Quoted in “Growth of AI in Mental Health Raises Fears of Its Ability to Run Wild”4 minute read
- Media CoverageBradley Merrill Thompson Quoted in “The FDA Plans to Regulate Far More AI Tools as Devices. The Industry Won’t Go Down ...2 minute read
- Media CoverageBradley Merrill Thompson Quoted in “NIST Releases New AI Risk Management Framework for ‘Trustworthy’ AI” ...3 minute read
- Media CoverageBradley Merrill Thompson Quoted in “Outlook 2023: The Regulatory Path Ahead”2 minute read
- Media CoverageBradley Merrill Thompson Quoted in “Torres Says Regulatory Alignment a Pressing Consideration for AI Change Control ...October 24, 20222 minute read
- Media CoverageBradley Merrill Thompson Quoted in “A ‘Disaster,’ or a ‘Clear Path’ Forward?: New FDA Guidance on AI in Medicine ...2 minute read
- Media CoverageBradley Merrill Thompson Quoted in “Racial Equity Increasing in Device Trials, but Reporting Remains Low”March 29, 20222 minute read
- Media CoverageBradley Merrill Thompson Quoted in “Top Med-Tech Trends of 2021: Regulatory Torpor Adding Drag to Advances in Artificial ...6 minute read
- PublicationsSenior Industry Leaders Need to Learn About AI3 minute read
- Media CoverageBradley Merrill Thompson Quoted in “After the Buzz, AI Finding Its Place in Health Care”2 minute read
- Media CoverageBradley Merrill Thompson Quoted in “FDA Regulation of AI Complicated by Hospital’s Use of In-House Algorithms” ...4 minute read
- PublicationsData Quality for AI in Healthcare2 minute read
- BlogsExploring Intentional Bias in the Marketing of Consumer Products4 minute read
- BlogsBias in Healthcare Algorithms5 minute read
- Media CoverageBradley Merrill Thompson Quoted in “FDA Promises a Draft Guidance for Change Control for Artificial Intelligence in ...2 minute read
- PublicationsPostmarket Responsibilities for Medical AI: Part III — FDA Should Not Expand Its Oversight of Commercialized AI ...3 minute read
- PublicationsPostmarket Responsibilities for Medical AI: Part II — What Industry Should Do in Commercializing Medical AI2 minute read
- PublicationsPost-Market Responsibilities for Medical AI: Part I – FDA's Plan to Increase Its Oversight3 minute read
- PublicationsFDA's Support of AI in Telemedicine2 minute read
- PublicationsNew Developments in FDA Regulation of AI2 minute read
Contact
EBG Advisors is prepared to assist you with undertakings ranging from launching products to obtaining regulatory approval and legal representation. Please provide us with an overview of how we may be of service, or if you have any questions, let us know, and we’ll direct them to the right consultant.
Joanna Pashos
Assistant Director EBGA
EBG Advisors, Inc.
JPashos@ebgadvisors.com
T: 202.861.1822